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THE RELATIONSHIP BETWEEN NEAT CONSUMPTICN AND THE
BIOIiCGICAI. DETERMINANTS OF CARDIOVASCULAR DISEASE RISK
by
Fred E. Kcllwitz, M.D.
Fasting blood samples were collected from 26 omnivore and 27 vege­
tarian men (35-60 years of age), who were not taking any medications and
The following analyses wereby self-assessment were in good health.
done: glucose (Glu), glycohemoglobin (HBA1), total serum cholesterol 
(chole), high density lipoprotein-cholesterol (HDD, low density lipo­
protein (LDL), very low density lipoprotein (VLDL), platelet factor four
(PF4), and beta-thromboglobulin (BTG). In addition, the blood pressure
(BP) was determined,.
The systolic (pCO.OOl) and diastolic BP (p=G.016) were lower in tine
vegetarian subjects than in the omnivores. The serum total cholesterol
levels were also lower in the vegetarian subjects compared to the omni-
There was no significant difference in Glu, HBA1, LDL,vores (p<0.05).
VLDL, HDL, PF4, and BTG levels between the two groups.
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The fact that coronary heart disease is a major health problem in 
the United States is no longer in question. The grim sad evidence of 
athersclerosis, seen in the autopsies performed on U.S. combat casual­
ties in Korea and Vietnam, revealed the presence of athersclerotic 
lesions in coronary arteries of 70% of those formerly healthy, active 
young men (with a mean age of 21.1 years). About 40% had moderate to 
severe occlusive lesions.^ Coronary heart disease is responsible for 
550,000 deaths per year and more than all forms of cancer combined.
It has been estimated that there are in the U.S. 5,400,000 Ameri­
cans with symptomatic heart disease, exclusive of a large number who 
have not been diagnosed. The dollar costs of this illness is approx­
imately $60 billion per year directly and indrectly. Males are at a 
higher risk than females, however, recent findings show females are 
closing the gap. Increasing age, obesity, diabetes mellitus, inactiv­
ity, and hypertension are also risk factors. These diseases are usually 
directly related to hyperlipidemia. Genetics has a strong influence on 
families who have a history of any of the aforementioned pathology. 
These diseases should lead to a screening of the children for plasma 
levels of cholesterol, LDL, HDL cholesterol, and triglycerides.2 It
probably behooves a pediatrician to be the "watchman on the wall" for 
future generations and to make a sincere effort to control the cardio­
vascular diease death rate.
The threat of cardiovascular disease, and what may be done to alter
these impressive mortality statistics has scientists searching for 
methods to make an early diagnosis. If an early diagnosis can be made,
1
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can anything be done to alter the present trend of morbidity and 
mortality? With this question in mind, we chose to investigate whether 
diet could be an important factor regarding the diagnosis and further 
progression of the pathology.
REVIEW OF THE LITERATURE
Platelets (Anucleated Cells)
The progenitors of platelets are the megakaryocytes which usually 
comprise a small portion (one per several hundred) of the marrow cells.
The megakaryocytes mature through the blast cell to the intermediate
stage, then to a mature megakaryocyte. It is at this stage that a
percentage of the cells will release or shed platelets. It is estimated 
that one human maegakaryocyte can release several thousand platelets.^
A number of proteins apparently unique to platelets have been 
identified (PF4, BTG, and a platelet derived smooth muscle growth fac­
tor). Some effects of these secretory proteins include stimulation of
smooth muscle cells, and cell proliferation, which may be important in 
the repair of vessel injury, 
other proteins that are present in plasma, that is, fibrinogen, factor
Platelets have also been found to contain
V, factor VIII, fibronectin, and factor XIII. In most instances it is
not known whether these proteins are absorbed or imbibed from plasma by 
mature platelets, or are synthesized de novo. Being enucleate, the 
platelet has only vestigial remains of protein synthetic apparatus, 
which implies protein synthesis in the megakaryocyte.^
The average lifespan of platelets is ten days. The younger plate­
lets are more active than the mature ones, and will promote hemostasis
at the site where microvascularization leakage occurs. The spleen
sequestrates approximately 30%, the liver 45%, the marrow and lymph 5-
15% of the toal number of platelets. Alcohol abuse can lead to
decreased platelets, and eventually to thrombocytopenia. This condition
can also be acquired in the case of megaloblastic anemia, secondary to a
3
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deficiency of either B12 or folic acid.^'^
The platelet count may fall as low as 10,000, to be followed by a 
rebound phenomenon, when the count may rise to 600,000 to 800,000 for 1- 
4 weeks of duration. Thrombopoietin is a hormone that stimulates 
platelet production in response to thrombocytopenic stress. In iron 
deficiency the platelets can be normal, moderately elevated or 
strikingly elevated, to a level of one to two million per cubic milli- 
meter. When this deficiency is corrected the platelet count returns to 
normal within one to two weeks. Hirsch and Dancie ^ reported the 
development of thrombotic complications in 5 of 15 patients whose plate­
let count was persistently high.
Platelet stimulation results in the activation of phosphorylases 
that hydrolyze the membrane phospholipid molecule, with the liberation 
of Arachidonic acid (AA). The AA is converted mainly to thromboxane A2 
(TXA2) in the platelets by the AA cascade.^
Platelet Secretions
There are two types of storage granules that are distinguishable in
the platelets. These are the dense granules which are homogenous and 
electron dense. The alpha granules are heterogenous, differing from one 
another and from the dense granules in size and shape.-1- Figure 1 will 
show this clearly.
The alpha granules may include acid hydrolases containing
organelles, whose content when stimulated is extruded into the cell's
environment. This specific extrusion is called "platelet secretion." 
Many of these substances have direct action on cells and on the
5
Figure 1: The stages of maturation through to the release of the 
platelet. In actuality the platelet is much smaller 
than the meta megakaryocyte. As diagrammed, the plate­
let is connected at the metamegakaryocyte via filamentous 
threads which also provide a physical structural network 
to stabilize the position of the platelet. The diagram 







E. Metamegakaryocyte with attached platelet


























platelets themselves and are converted to physiologically active sub­
stances in the plasma or on the cell surface. The result of "in vivo" 
platelet activation may vary from a "simple" change in the structure of 
platelet membrane to the complete release reaction. Stimuli unable to 
promote a complete release reaction may, however, be sufficient to
determine a partial activation resulting in the release of alpha gran­
ules.^ Serotonin is absorbed and secreted by platelets, 
they contain substantial actomyosin and this release is promoted by
In addition,
extracellular calcium ions that can enter intercellularly under the
Once inside the cell, they cause the organellesinfluence of thrombin.
to contract.
It is important to know that some of the plasma protein analogs, 
such as fibrinogen, come from the alpha granules. However, they are 
probably not a product of the granules. Therefore, megakaryocytes or 
platelets do not synthesize fibrinogen, but accumulate it by some un­
known method.^
Platelet Factors 1, 2, 3, and 4
Although there are specific substances that will selectively stimu­
late platelets, one experimental product is a cationophore A-23187.^ 
This, as well as other substances, will stimulate the secretory proces­
ses of the alpha dense granules and a general platelet response, 
is a change in shape, aggregation and AA liberation, Arachidonic is sub-
There
sequently oxidized to a platelet activating substance, TXA2.
8,9,10
Some
strong platelet aggregation inducers are ADP collagen, epine­
phrine, TXA2, and thrombin; however, these are dependent upon the avail-
8
ability of calcium, therefore, calcium channel blockers are inhibitors
of platelet secretion to a limited degree.
Another secretory platelet factor is the platelet growth factor, 
which is capable of stimulating the proliferation of smooth muscle
cells. This is of great importance in the formation of atheromas.
Platelet factor 1 refers to coagulation factor V in the platelets.
Platelet factor 2 accelerates the clotting of fibrinogen by thrombin;
and these terms are no longer used. Platelet factor 3 has a phospho­
lipid like activity, and platelet factor 4 has an anti-heparin like 
activity. Phospholipids make up 76% of the total lipids and are approx­
imately constituted as follows: phophatidyl choline (which is a surfac­
tant), phophatidyl ethanol amine and sphingomylin. Neutral lipids con­
stitute 20%, the remaining 4% are lipoproteins. The lipids cement the 
membranes and at the same time serve a biological function.^
There are two types of PF4; one protein is regular, or normal PF4, 
and is a high affinity protein; the other is a low affinity PF4 (LA-PF4) 
at times also referred to as platelet factor 3 (PF3).^'5
Some characteristics of PF4 are as follows: it is a low molecular
weight protein, glycoprotein found in the alpha granules, released from
the platelets by releasing factor followed by stimulation and aggrega­
tion by ADP, thrombin, and epinephrine.^^ Platelets in a quiescent
state have a convex surface with random indentations representing sites
of communications between channels on the surface, either connected or
are open canalicular systems to the exterior of the cell (Figure 1).
This system provides for the orderly access to the interior of the cell
for plasma-born substances, and the egress for products of the release
9
reaction. Two proteins, a high affinity PF4 and a low affinity PF4 are
secreted by the platelets. The hydrolitic cleavage product of the 
latter, produced by platelet proteases, is called beta thromboglobulin.
both PF4 and BTG bind heparin. Their levels in circulating plasma are
regarded as a measure of platelet activation in vitro. PF4 is a low
molecular weight protein that is immunologically specific for platelets.
and all experimental evidence suggests that most of the proteins are 
stored in the alpha granules.-^
The dense granules contain the minerals and vitamins, namely Ca, 
Mg, Zn, folic acid, ascorbic acid, and cyanocobalamine. Platelets of
themselves do not produce serotonin, but store it as a smooth muscle
vasoconstrictor. Consequently, serotonin is absent in the plasma and 
other cells. There is no reliable method of measuring serotonin except 
biopsy of the sites of production, namely brain cells and argentofil
cells of the small intestines. Serotonin has not been found to be
7important in hemostasis in humans, but may be so in other species.
The two types of platelet granules are known as storage granules.
The reference "dense granules" implies that they are homogeneous and
electron dense. If there is a deficiency of these, it is called a
"storage pool deficiency," with the resultant impaired homeostasis. The
alpha granules are heterogeneous and differ from one another an from the
dense granules both in size and shape. All platelets have complete
cellular elements. As mentioned earlier they are anucleated, therefore, 
they do not have DNA.^
10
Functions of PF4 and LA-PF4
1. PF4 shortens the cascade of thrombin acting on fibrinogen to
fibrin, thereby reducing the time for clot formation.
In the presence of heparin PF4 will potentiate ADP induced2.
aggregation n vitro to induce precipitation of fibrinogen, which is
normally soluble in plasma.
3. PF4 will non-enzymatically clot or precipitate soluble fibrin­
ogen in plasma. PF4 will neutralize certain fibrinogen breakdown
products; may be a potent and specific agent triggering platelet aggre­
gation, thereby shortening the time for blood clotting.
4. The levels of PF4 in plasma are 3-16 ng/ml. These values are 
the range of what is commonly accepted as normal. French, et al , as a 
result of their studies of thrombospondin BTG and PF4, suggest 34 ng/ml
for BTG and 6.1 ng/ml for PF4. PF4 binds very tightly to heparin to 
neutralize its anticoagulation activity. LA-PF4 binds to low affinity 
heparin, and is immunologically identical with BTG.
5. LA-PF4 is acted upon in the circulation to convert to BTG by 
splitting off the tetrapeptide from the end terminal of LA-PF4.
6. Both LA-PF4 and PF4 are secreted simultaneously and have anti-
8
heparin effect. Then the LA-PF4 is converted to BTG in the plasma. The
PF4 is cleared more rapidly due to the substance adhering immediately to
the endothelial cell surface, whereas BTG, a derivative of LA-PF4 with
8,12low heparin inhibiting effect, remains in the plasma longer.
Beta Thromboglobulin (BTG)
The name was given because it migrates in cellulose acetate in the 
beta-globulin region. The complete primary structure of human BTG is
11
known and consists of 81 amino acids, with a molecular weight of 8,851. 
The amino-acid sequence of BTG shows a marked homology to PF4 in that 42
8of their residues are identical. The only difference between LA-PF4
and BTG are four amino acids. Experimental evidence suggests that La- 
PF4 is originally secreted by the platelets during the platelet release 
reaction, and subsequently converted to BTG by a heat-labile platelet 
derived neutral protease or by plasmin.5 Plasmin, fibrinolysin, or
neutral protease split off a tetrapeptide from the end terminal of LA- 
PF4, to yield BTG.
cells and thereby inhibits production of prostacyclin formation.-^ BTG,
8 Some researchers feel that BTG binds to endothelial
LA-PF4, and PF4 are immunologically specific for platelets, since they
do not occur in any other cells or tissues. In platelet free plasma
levels are 500 times less than in platelet rich plasma, 
basis for the test to measure their quantity in circulating blood as an 
indicator for thrombogenesis.-^
This is the
One of the most crucial steps in the preparation of PF4 and BTG 
tests is to make a careful preparation of the specimen by avoiding any 
leakage of the coagulating proteins into the platelet free preparation.
Apparently the half-life of PF4 is so short that is cannot be measured 
according to Daws^ and others.-1-5 The half-life of BTG is estimated to 
Other researchers^ find the half-life of thesebe 100 minutes. pro­
ducts to be divided into two periods; namely, an inital rapid loss.
followed by a slower loss.
BTG may act locally at high concentration to favor platelet 
aggregation by inhibiting PGI2 production. The binding sites of BTG ,are 
specific and will not accept PF4 on their sites. LA-PF4 and LA-BTG
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accordingly regulate although they do not have similar biological
effects.-^
BTG and PF4 acting in concert, yet independent of one another, are 
involved in thrombin formation. Forbes-^ in his experiment, measuring
the levels of BTG and PF4 in patients with transient ischemic attacks 
(TIA) has shown that both these levels continue to remain high as long
as two months after an attack. This is in agreement with the results of 
Fisher^, Stewart-^, and it has been concluded that the highest values 
carried a poor prognosis. The results of these authors are completely 
opposite to those of de Boer, et al^, who in 1982 reported no change in
BTG, PF4 plasma levels within 48 hours of a stroke. A plausible explan­
ation of the difference between these authors is offered by O'Brien and 
Etherington^, who suggest measuring intra platelet levels of PF4 and 
BTG to yield more reliable information. The plasma level of any one 
moment will depend upon the balance between the rate of release of the 
protein from the platelets and the rate of its removal from the blood.
which is fast, the half lives of PF4 and BTG being about 20 minutes and 
100 minutes respectively.^^
Fabris^ has shown a high specificity for PF4, BTG to antiplatelet 
drug therapy. When patients used combinations of dipyramidole (anti­
platelet aggregator) with aspirin there was no effect on PF4 or BTG
levels; both remained at pathological levels. This is also true for the
patient with coronary artery disease. Either dipyridamole or aspirin 
alone are effectively-
increased cardiovascular morbidity and mortality has been estab­
lished to be higher among smokers than among non-smokers. Previous data
13
has shown normal individuals could prevent an incrase in PF4, BTG levels 
if the individual took aspirin prior to smoking. The study of Davis, et 
al^, was of men who were habitual smokers and who had coronary artery
disease. Their data indicated that smoking stimulated platelet aggre­
gate formation and the release of the content of alpha granules were 
unaffected by the previous administration of aspirin.
Distribution and Function of Lipoproteins and Aprooroteins
In the previous pages of this thesis we have referred to the var­
ious lipoproteins, and the accompanying diagram (Figure 2) will explain 
the relationship of the lipoproteins to the apoproteins. This relation­
ship is important for futher understanding of the cardiovascular risk 
factors and the cardiovascular protective factors.
Factors HDL, LDL
While we speak in generalities about HDL and LDL, we must be aware
To illustrate HDL, there are three sub-that there are subfractions.
fractions: HDL-1, HDL-2, HDL-3. HLD-2 is a beneficial subfraction for
human beings, and may be raised with exercise and dietary intervention.
In thisThe LDL fraction has been divided into LDL1 and LDL2.
thesis I shall consider both LDLi and LDL2 as LDL and avoid mentioning
the subfractions.
Analysis for possible correlations between HDL and total choles­
terol and other lipids and lipoprotein fractions demonstrate a moderat­
ely strong negative correlation between HDL cholesterol and triglyc­
erides which was consistent when measured in the general population,
14
Figure 2: Summary of percentage distribution of lipids in the 
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Table 1: Composition and Function of Human Lipoproteins
Apoprotein Lipoprotein Function
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except for females. There are indications that increased serum choles­
terol is the most important risk factor before the age of 50 years. 
Triglycerides have small negative correlation with LDL, except in fe­
males, and a moderate correlation with total cholesterol. As was expec­
ted, there was a strong correlation between LDL and total cholesterol.
Statistical analysis indicates that HDL and LDL cholesterol were inde­
pendent and significant factors in coronary heart disease prevalence. 
Because the inverse correlation between HDL, cholesterol and triglyc­
eride levels, the role of triglycerides as an independent risk-factor
was not found to be signficant on multiverate analysis, except for
OO
females.
Freinkel^ states that weight loss, nicotinic acid and clofibrate
treatment lower VLDL and raise HDL levels. He states that diets high in 
carbohydrates have the opposite effect on the levels of these two lipo­
proteins. In all these conditions, reciprocity appears to be present
between HDL and VLDL levels. The only known exception to this general­
ization are alcohol consumption and estrogen treatment, both of which
raise HDL and VLDL levels.
HDL
With a balanced diet, the mean synthetic rate for HDL protein was 
8.5 mg/kg/day.^
particle size, a lower ratio of apoA-1 to apoA-II in HDL, and a larger
Carbohydrate feedings resulted in a smaller mean
portion of the total plasma HDL present in the smaller HDL-3 fraction. 
In all of these repects, reciprocal changes were seen with nicotinic 
acid treatment. Both perturbations had very little or no effect on the
18
synthetic rate of HDL protin. Major effects, however, were seen on the
HDL catabolic pathway. Thus the high-carbohydrate diet significantly
increased the rate of HDL protin catabolism from the plasma compartment
(and lowered plasma HDL level), whereas nicotinic acid had reciprocal 
effects.-^Triglycerides rise during a low fat diet because carbo­
hydrates induce the synthesis of VLDL triglycerides, however, the claim
has been made that the rise ini triglyceride concentration accompanying
a high carbohydrate diet abates when such a diet is prolonged.
Some reflections on HDL are as follows: lowering of HDL can be
caused by reduced levels of the enzyme lecithin cholesterol acyltrans­
ferase (LCAT) or reduced levels of apoA-1 and HDL levels can be very
low, a finding that is associated with premature atherosclerosis.
Shephard, et al,25 who studied a tenfold increase of the P/S ratio
(from 0.4-4.0) in his subjects showed a decrease in HDL cholesterol and
This has been confirmed in other studies^ of infantsapo protein A-l.
and formula manipulations to affect the outcome. From this and several
2,25 some consistency is emerging with regards to theother reports
effect that diets high in polyunsaturated fat (P/S ratio from 1.6 to
4.0) are associated with lower concentrations of apoprotein A-l and HDL
cholesterol than a low intake of polyunsaturated fats (with a P/S ratio
It also appears, however, that a wide range of dietary 
cholesterol (20-5,000 mg/dl) has little effect on HDL cholesterol and 
apo protein A-l, although LDL and total cholesterol rose.26'27 
Study26 and Multiple Risk Factor Intervention Trial2^ have been cited as
from 0.25-0.45).
The Oslo
evidence that polyunsaturated fat does not alter HDL cholesterol concen­
tration in humans. In neither study did the P/S ratio exceed 1.0, and
19
since the populations were free living, even this ratio cannot be docu­
mented. The apparent lack of reduction in HDL concentration might be 
attributable to the populations studied.
LDL Cholesterol
Earlier in the thesis it was stated that we would consider LDL as
one entity; however, there are two LDL cholesterols. It is a point of 
interest that there is a normal LDL cholesterol and what might be con­
sidered an abnormal LDL cholesterol, the latter having as its charac-
nteristics a low molecular weight and abnormal chemical composition.^ It
is this latter one that is elevated with a typer apoB, and is character­
istic of those people with an endogenous hypotriglyceridemia. This is 
associated with the atherosclerosis and those who would appear at great- 
er risk for coronary artery disease.
Biological and Hematological Variables in Vegetarians
Some literature states that vegetarians have lower serum choles­
terol than non-vegetarians, and a lower prevalence of ischemic heart
disease than the general population. Earlier studies (West and Hays, 
1968; Sacks, et al, 1975; Burslem, et al, 1978) confirm previous observ-
vations that vegetarians have a lower blood cholesterol than non-vege­
tarians. Although the HLD cholesterol was the same for both groups, the
vegetarians had a higher HDL as a percentage of the total cholesterol. 
This was in accord with Gears'^ report. Some variables to consider are
the vegetarians' higher fiber intake, difference in life styles, general
interest in healthful living and family, and often non-smokers. Vege-
20
tarians are usually leaner than non-vegetarians, yet in subjects that
were matched this did not account for a difference in the lipid level 
which could be demonstrated in pairs of subjects matched for weight. 
The study done by GearJU stated that the difference in cholesterol
concentration might be because of a difference in saturated fat intake.
rather than because vegetarians have a higher intake of dietary fiber.
Vegetarians with a saturated and a monounsaturated intake of over 50
gm/day had a mean plasma cholesterol concentration of 239 mg ml, which 
is similar to that of non-vegetarians. No relationship was apparent
between cholesterol and dietary fiber. The difference between blood
glucose and high density lipoproteins (HDL) expressed as a percentage of
total cholesterol was small but consistent and statistically signifi­
cant.*^^
In the above study, the ratio of cholesterol to HDL in a vegetarian
was 3.26 and that of the non-vegetarian was 3.86; small but consistent, 
and statistically significant (the percentage of HDL in a vegetarian was
30.6 and percentage of HDL in a non-vegetarian was 25.2). It is inter­
esting to note that he reported identical HDL values for both vege­
tarians and non-vegetarians.-^ Burr, et al*^ in his report, found that 
85 vegetarians showed an average of lower cholesterol and a higher HDL 
than 214 non-vegetarians. The Burr, et al,^ value of percentage of HDL
with vegetarian was 24.35 and non-vegetarians were 19.28. The values 
represent men of less than 60 years of age.^***
Blood Pressure in Vegetarians and Omnivores
The mean systolic and diastolic pressure showed no consistent or 
significant differences between vegetarian and nonr-vegetariaru^l This
21
is in contrast with some of the findings of Sacks, et al^ (1975) and 
Armstrong, et al*^ (1979), who reported lower systolic and diastolic 
pressures in vegetarians, although the results were not large.
A recent study done in London on various disorders among omnivores 
and vegetarians showed a "significant downward trend in disease prevar- 
lence with the adoption of vegetarian-vegan diet." Angina pectoris was 
diagnosed in omnivores in the fifth and sixth decades of life, and in 
the lifelong vegetarians not until the seventh and eighth decades of 
life.34
PURPOSE
Blood pressure, glycohemoglobin, total cholesterol, HDL choles­
terol, cholesterol HDL ratio, LDL, Platelet Factor 4, and Beta Thrombo-
globulin were compared between a group of vegetarians and omnivores.
The gross pathological anatomy of myocardial infarct has been well
appreciated for many years. The micro-pathological anatomy is still in
the unfolding stage and for this reason the study of PF4 and BTG was
chosen. We limited our patients to vegetarian and omnivore males whose
Our source of patientspresent ages were between 35 and 60 years old.
were those who had previously been in the Adventist Health Study of 
1978. There were a total of 312 names in this previous study, of which 
we randomly selected 27 vegetarians and 26 omnivores from the list. All
of those who consented and met the criteria were accepted for the study.
22
METHODS
I personally telephoned each participant and talked directly with 
him, discussed the tests that were planned and of what value they would 
be to him regarding his health. An option was offered to the patient, 
to either mail the results directly to him, or to the physician of his 
choosing. We made no attempt to discuss the results, other than to 
point out those results which were out of the normal ranges. We mailed 
each patient his results and made ourselves available for any further 
inquiry from their physician. This was done to avoid any potential of 
malpractice implications to either the University or team members. At
the outset of the telephone conversations we did a survey concerning 
their self-appraisal of their own health. That is, we questioned them
as to whether they were, generally speaking, in good health, 
aksed if they had any known diease for which they were being treated.
We also
All of our candidates met the above mentioned standards. In addition,
none were taking medications on a regular basis.
The patients were mailed a consent form and brought it with them 
the morning of the phlebotomy.
tions to the participant for the drawing of their fasting blood, 
blood sample had a minimum of a 12-hour fasting state.
The majority of patients were physicians, dentists, or allied 
health professionals who were assumed Seventh-day Adventists living 
within a radius of 15 miles from the Loma Linda University Graduate 
School, Department of Nutrition, 
teers were using tobacco in any form, since it is prohibited by the 
Articles of Faith for Seventh-day Adventists.
Included in the mailing were instruc-
Each
We assumed that none of these volun-
23
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Each candidate was allowed to be seated for a few minutes in order
to relax prior to measuring his blood pressure (BP) in each arm. The 
antecubital fossa was prepared in a routine manner for the phlebotomy. 
The BP cuff was kept in place and maintained at a level between the 
systolic and diastolic levels? this was done to facilitate the ease of 
phlebotomy. Two separate 20cc disposable syringes were used per pa­
tient, and each syringe had blood drawn up to the 15 ml mark. The #20 
gauge disposable needle was left in the vein during the syringe changes. 
Prior to taking blood into the second syringe, we allowed a free flow of 
blood for approximately 3-5 cc before connecting the syringe. This was 
done to minimize any platelet disturbance or extraneous clotting mater­
ial from contaminating the sample. The first syringe of blood was 
promptly put into respective tubes with anticoagulant material. The 
second syringe of blood was put into separately labelled PF4, BTG tubes 
for radioimmunoassay (RIA). The blood was gently allowed to run down 
the side of the tube to limit any physical disturbances to the cells. 
When filled, the tube was put into an ice bath until a sufficient number 
of tubes were collected to continue the next step in the procedure, 
which was to centrifuge the specimens at a precalculated speed of 3,200 
rpm in a temperature controlled centrifuge at 2-4 degrees Centigrade for
30 minutes.
The tests performed for glucose, glycohemoglobin, total choles­
terol, and high density lipid analysis were done utilizing Sigma Chemi­
cal Company laboratory kits. The procedures outlined in the kits were
followed very carefully to ensure good laboratory results.
It was physically impossible to do all of the lab testing in a
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single day, therefore, the plasma was frozen when not in use, and stored 
to be available as needed. Thawing and refreezing was avoided and the 
samples were used as needed for that day. Several of the fasting blood 
sugars were run on whole blood and some on plasma. The LDL and VLDL 
values were done by the Faculty Medical Laboratoy.
The PF4 RIA diagnostic kit was supplied by Abbott Diagnostic 
Laboratories.
The Amersham Corporation has available a thrombotect kit for the
BTG, which was used to measure BTG. Both the PF4 and the BTG are RIA
procedures.
RESULTS
Table 1 shows a significant difference in p values in both the 
systolic and diastolic BP of vegetarians vs. omnivores. The obvious
results show the vegetarians are significantly lower. When we recorded 
the BP of our subjects, we took the pressure in each arm and then 
recorded the average of the two systolic readings and the average of the 
diastolic readings.
Tables 2 and 3 dealing with glucose in the fasting state and the 
glycohemoglobin show no statistical difference between the vegetarian 
and the omnivore. This is somewhat unexpected since other literature 
shows significant differences between these two groups, largely as the 
result of the vegetarian having a higher complex carbohydrate diet and 
with its associated glucose lowering effect.'^,•^'^
The lipid profile, as seen in Table 4, does show significant dif­
ference in the cholesterol and the cholesterol high density lipid ratio 
betwen the vegetarians, who have lower levels, and the omnivores, who in 
turn have higher levels. The HDL and LDL showed no significant dif­
ference.
However, in Table 5 the p value on the LDL studied showed 0.07, 
which almost reached a value of significance between the vegetarian and 
the omnivore groups.
Table 6, the last part of this study, involved PF4 and BTG. These 
showed no significant difference between either vegetarian or omnivore.
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Table 2: Means of right and left arms systolic and diastolic blood 
pressure of vegetarians (23) and omnivores (25). Five 
readings are missing separate variance estimates (itmHg + S.E.)
Systolic BP Diastolic BP
Vegetarians (23) 106.2 +2.5 74.2 ± 2.2
Cmnivores (25) 121.7 ± 3.1 83.5 ± 2.3
Recorded readings of patients in seated and related position. 
pKO.Ol vegetarians vs. omnivores
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Table 3: Fasting blood sugar values of vegetarians and annivores.
Fasting levels are an overnight fast of 12 hours (mg/dl + 
S.E.)
Fasting 
Blood Sugar P Values
Vegetarians (27) 95.8 ± 6.2 N.S.
N.S.Crnnivores (26) 98.2 ± 3.4
N.S. - Not Significant
Normal fasting glucose levels 60-110 mg/dl
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Table 4: Determination of glycohemoglobin in vegetarians and omnivores 
(mg/dl + S.E.)
Glycohemoglobin P Values
Vegetarians (27) 6,5 + 0.52 N.S.
Omnivores (26) 6.2 ± 0.42 N.S.
N.S. - Not Significant
Normal Glucohemoglobin levels 4.0 - 9.6 mg/dl
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Table 5: Overnight 12-hour fasting levels of plasma cholesterol and 




200.4 ± 8.8* 47.3 ± 2.6 4.5 ± 0.34*
Omnivores
(26)
235.3 ± 11.3 43.7 ± 2.9 5.9 ± 0.44
* p<0.05 canparing vegetarian with ormivore
Normal cholesterol levels 125-220 md/dl
Normal cholesterol/HDL levels (male) <4.97 md/dl
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Table 6: Overnight 12-hour fasting levels of plasma LDL for vegetarians 
and omnivores (mg/dl + S.E.)
LDL
Vegetarians (16) 144.6 ± 7.4 N.S.
Qnnivores (12) 181.7 ± 18.1 N.S.
Normal LDL levels 66-178 md/dl
HDL and LDL were performed by Lora Linda University Faculty Medical 
Lab.
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Table 7: Radioinmunoassays for PF4, BTG on vegetarians and annivores.
PF4 BTG
Vegetarians (27) 38.2 ± 6.3 67.8 ± 13.0 N.S.
Qnnivores (26) 38.1 + 6.8 87.1 ± 17.1 N.S.
DISCUSSION
The findings in this study concerning the BP were consistent with a 
great many other authors, as stated earlier in this thesis. There
was a significant decrease in both systolic and diastolic values when 
the vegetarian is compared to the omnivore. Yet, Burr, et al,31 who in
1981, while studying plasma cholesterol and BP in vegetarians, found no 
consistent or significant difference between vegetarians and non-vege­
tarians when measuring the mean systolic and diastolic pressures. These 
findings may be related to some of the health habits of some Seventh-day 
Adventist vegetarians, in that they do not drink any caffeine, or very 
limited amounts, whereas the study of Burr, et al,3^ may have not had
this variable controlled.
Concerning glucose and glycohemoglobin, it was anticipated that 
both of these values would be reduced.^'33 One of the reasons, maybe, 
that there was no difference between vegetarians and omnivores might be 
due to no known history of diabetes in either one of the groups studied. 
The literature is replete with references for the treatment of both type
I and type II diabetes by increasing the complex carbohydrates and 
lowering fat.^'32,35 This makes a significant change, lowering glucose 
and glycohemoglobin. This is one of the goals which the American Dia­
betic Association strongly endorses. The men stuied were of above 
average intelligence, and for the most part were health professionals; 
they may have been aware of the value of complex carbohydrates in their 
diet and consumed more in their diets than non-professionals.
Table 3 showed both cholesterol and cholesterol/HDL ratio indica­
ting significant differences between the vegetarian and omnivore. Earl-
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ier studies by West, Hayes, and Gear also show significant reduction in 
these values among vegetarians, compared to omnivores.
The LDL and the VLDL values showed no significant differences.
However, as noted earlier, the p value for the LDL was .07 and almost of
Even though the lab results are in a normal range.significant value.
the vegetarians in this study are somewhat at risk if we would assume
that 100 mg/dl or more would put a person at risk.
The RIA as shown in Table 6 showed no significant difference be­
tween the PF4 and BTG of the two groups studied. PF4 normal values are 
13 ng/ml and BTG 50 ng/ml. Perhaps there is not any significant dif­
ference in either PF4 or BTG, in what appears to be normal health
patients, and any differences may be relevant when cholesterol levels
are higher than what these subjects have.
There was no significant correlation between the following:
total cholesterol and PF4
total cholesterol with BTG
HDL with PF4
HDL with BTG
systolic BP with PF4
diastolic BP with PF4
systolic BP with BTG
diastolic BP with BTG
PF4 with BTG
systolic BP with cholesterol
diastolic BP with cholesterol
systolic BP with HDL
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diastolic BP with HDL
systolic BP with glucose 
diastolic BP with glucose
systolic BP with HBA1 or
glychoheinoglobin or diastolic BP with HBA1.
CONCLUSIONS
If this experiment were repeated again, I now am aware of a number
of variables that should be controlled in a future study. Some of the 
variables are to try to make an estimate of the number of large and
small platelets, evaluate if there is a possible iron or vitamin B12 
deficiency which could affect the platelet count, and any recent pre­
vious platelet count to evaluate with the present platelet count, there­
by evaluating if rebound phenomena are present. Some of the anti­
platelet factors that were not considered in this study were whether or
not the patient had ingested aspirin within five days prior to his
phlebotomy, what amount of fish the omnivore is eating (involving omega-
3 fatty acid ingestion, thus influencing platelets), what individual 
donor thrombopoiesis accountability, the matter of platelet separation 
(the force of centrifugation) and the specific gravity of the centrifuge 
media, the variation in platelet concentration affecting platelet meta­
bolism due to thrombocytopenia and/or thrombocytoses, mainain the syr­
inges in a cool temperature and be certain that the assistances minimize 
physicaol disturbance to the samples. Smoking has been overlooked as a 
risk factor in my study. I would also wish to know how much exercise 
that person does on a regular basis, and to what extent he drinks
coffee. Frederickson's classification would have organized the group­
ings of those patients who had an elevated cholesterol. If we would
have had their classifications, we would have an approximate idea of the
concentrations of HDL, VLDL, and LDL.
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SUMMARY
The vegetarians (26) versus omnivores (27) showed significant de­
crease in systolic BPf diastolic BP, chole, RHDL while the LDL, Glu, 
HDL, VLDL, PF4, and BTG, as well as correlation between these values, 
were not significant by statisticaly analysis.
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09 717212618 7.8292265.1122/82 99
750919 1554.2512165.1108/78 99
603120 1854.4239 5492100/68 4.4
21 6743.6 16162223120/80 99 4.6
22 44782 5.2 345427110/80 3.3104
23 429512239 4.1161110/70 95 5.5
24 1808815036 5.2186108/86 91 4.1
25 180961784.6228 50110/80 4.993
26 100 1702477.5382855.1110/66 93






Appendix A Continued 42
Omnivore
CHOLES
WENT BLD PRESS GLUC Hb AlC CHOLES LDL PF-4 BllZHDL HDL VLDL
1 138/86 208113 4.5 133 47 2.8 9
2 230 23510.6 66 36145 3.4
3 120/70 225134 4.2 178 66 922.6
4 205118/75 14128 5.4 318 47 6.8
5 196146/106 6294 5.4 281 44 6. 4
6 52 118122/88 7.9112 5.8 244 31
7 3014112/68 103 5.7 23 7.9181
8 ■35128/100 10103 5.9 23 11.3259
9 232144/102 83 8.5 204 38 45.4
10 23536120/94 ' 212 5.275 7.5 41
11 262120/82 10.8 8875 9.3 216 20
12 118/84 26 22385 8.9 278 31 9.0
13 280160/102 10.0 4975 275 5.847
14 280100/72 3880 10.5 6.0245 41
15 07148/86 14438 6.2 19896 6.4 236
16 280132/94 126 0596 4.9 177 51 3.5
17 09 6331118/88 92 4.6 259 6.3 18741
18 09 71122/82 29 126 7299 5.1 226 7.8
19 09 75108/78 4.2 15599 5.1 216 51
20 100/68 92 60239 185 314.4 54 4.4
21 120/80 99 4.6 223 62 3.6 161 674
22 110/80 104 3.3 427 82 5.2 345 7 44
23 110/70 95 5.5 161 39 4.1 122 95 42
24 108/86 91 4.1 186 36 5.2 150 88 180
25 110/80 93 4.9 228 50 4.6 178 96 180
26 110/66 93 5.1 285 38 7.5 247 100 1 70
X 98 6. 0 233 44 52176 41 159
X 96 5.5 228 41 161 26 180
Mode 0 0 0 0 0 2809
Midrange 110 7.3 280 51 233 52 205 m





1. Today's Date: / / /
mo day yr
2. Date of Birth / / /
mo day yr
3. Sex: Male [ ] Female [ ]
4. Has a doctor ever told you that you had any of these conditions?
Mark "yes" only for conditions diagnosed by a doctor, even if the 
condition is no longer present. Be sure to mark "no" for conditions 
you have never had.
4a. Heart attack or coronary (myocardial infarction) No [ ] 
Yes [ 3
4b. Stroke or apoplexy No [ 3 
Yes [ 3
4c. High blood pressure No [ 3 
Yes [ 3
4d. Diabetes No [ 3 
Yes [ 3
4e. Cancer or leukemia No [ 3 
Yes [ 3
5. Please list the prescription drugs you have taken in the last 30 
days: (Please print)
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Health Questionnaire Continued 44
Please list the non-prescription drugs (e.g 
Tylenol, Contact) that you have taken in the last 30 days (please 
print):
aspirin, Bufferin,6. • r
What is your best estimate of your present weight and height in 
normal indoor clothing without shoes?
7.
a. Current height ft in.
b. Current weight lbs
APPENDIX C
School of IIcalt.li 
Department of Nutrition 
Loma Linda, California 92354 
714/824-4598
Lorna Linda University
Consent Form for Diet and Health Study
, hereby agree to participate in this studyI,
on the relationship between dietary factors and cardiovascular disease risk.
Specifically we will be measuring blood pressure, blood cholesterol and other
blood fats, blood sugar and blood clotting.
As part of this study, I have agreed to complete a questionnaire about
my diet and lifestyle and to spend approximately one hour or less at the
I have agreed to not eatFaculty Medical Offices located in Loma Linda.
anything after 10 p.m. the evening before my visit to Loma Linda, however
Furthermore, I will not eat breakfast on the dayno limit for plain water.
of my visit to Loma Linda.
During my visit to Loma Linda, I have been told that two samples of
The bloodThe blood will be drawn by a physician.blood will be drawn.
measure the amount of bloodsamples will be used to detect diabetes,
cholesterol and other substances related to the clotting action of my blood.
Each sample will consist of approximately three tablespoons of blood (i.e.,
It is possible that a small amount ofapproximately 30 cubic centimeters).
blood may temporarily accumulate at the site on my arm where the blood is
This may cause the site to become slightly discolored like a smalldrawn.
(This is only a temporary condition and is a common conditionbruise.
My blood pressure will also be taken during myfollowing blood drawing.)





School of Health 
Department of Nutrition 
Loma Linda, California 92354 
714/824-4598
flfioLoma Linda University • '
I have been told that I can request that my study results on blood
These study resultschemistries and blood pressure be forwarded to me.
high blood pressure, and highmay alert me to the presence of diabetes,
blood cholesterol.
I have been told that all the information collected in this study will be
My name will never be associated with any of thekept strictly confidential.
data released from this study.
While the risks involved in this study are minimal, I have been told
that emergency treatment is available should a health problem develope
(714)I should contact Glenn Sharmannduring my Loma Linda visit.
I824-4634, Patient Representative, for information and the required forms.
also have been told that I am free to withdraw from this study at any time.
I may call Dr. Blankenship at (714) 824-4300, ext. 7172 if I have questions
about this study.
I have read theAfter signing this form, I will receive a copy.
contents of this consent form and questions regarding this study have been




Signature of Investigator Date
